Fingerprint
Dive into the research topics of 'Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically